Progyny, Inc.
PGNY- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001551306
In the last 90 days, Progyny, Inc. insiders filed 0 open-market purchases and 2 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.26B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $382.8K in total
- 2
- 13F holdersQ2 2026, +21 vs. previous quarter
- 311
- 13F valueReported value at the end of Q2 2026
- $2.26B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PGNY, Q2 2026
No superinvestor reported holding PGNY at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Progyny, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)6:46 PM ET | Sep 10 | 8 days | Gordon Kevin KDirector | SSale | −11.5K | $27.12 | −$311.9K | −62.9%6.79K after | Amended |
| Jul 16, 2026 (view filing)4:16 PM ET | Jul 14 | 2 days | Cummings Melissa BChief Operating Officer | SSale | −2.24K | $31.60 | −$70.9K | −3.1%69.9K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Livingston Mark S.CHIEF FINANCIAL OFFICER | SSale | −2.52K | $25.50 | −$64.2K | −3.3%74.7K after | 2 lots10b5-1 |
| Jun 5, 2026 (view filing) | Jun 3-4 | 2 days | Swartz AllisonEVP, GC | SSale | −1.80K | $25.04 | −$45.0K | −2.1%82.4K after | 2 lots10b5-1 |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Livingston Mark S.CHIEF FINANCIAL OFFICER | SSale | −279 | $26.20 | −$7.31K | −0.4%78.6K after | 10b5-1 |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Scott CherylDirector | SSale | −7.44K | $26.39 | −$196.3K | −27.3%19.8K after | |
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Clapp GeoffreyChief Product Officer | SSale | −1.53K | $25.58 | −$39.1K | −2.5%59.1K after | |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Swartz AllisonEVP, GC | SSale | −2.40K | $25.46 | −$61.1K | −2.7%85.2K after | 10b5-1 |
| May 29, 2026 (view filing) | May 27 | 2 days | Gordon Kevin KDirector | SSale | −5.50K | $24.99 | −$137.4K | −37.1%9.32K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Livingston Mark S.CHIEF FINANCIAL OFFICER | SSale | −8.28K | $25.50 | −$211.0K | −9.5%79.1K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Progyny, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,599,921 | $334.4M | 0.00% | −398,546−3.3% | Reduced |
| FMR LLC | 7,004,280 | $201.9M | 0.01% | +503,461+7.7% | Added |
| Vanguard Portfolio Management LLC | 5,019,465 | $144.7M | 0.01% | −272,563−5.2% | Reduced |
| Vanguard Capital Management LLC | 3,210,723 | $92.6M | 0.00% | −270,616−7.8% | Reduced |
| State Street Corp | 3,022,859 | $87.1M | 0.00% | −57,434−1.9% | Reduced |
| Ameriprise Financial Inc | 2,763,514 | $79.7M | 0.02% | −61,817−2.2% | Reduced |
| Fort Washington Investment Advisors Inc | 2,548,164 | $73.5M | 0.37% | −145,229−5.4% | Reduced |
| Geode Capital Management, LLC | 1,969,208 | $56.8M | 0.00% | −73,757−3.6% | Reduced |
| Citadel Advisors LLC | 1,785,717 | $51.5M | 0.03% | +1,785,717 | New |
| Dimensional Fund Advisors LP | 1,688,670 | $48.7M | 0.01% | +115,245+7.3% | Added |